Loading…
LB Pharmaceuticals Inc is projected to rise to $50.27 by 2027, a +25% move from its current price of $40.08. LBRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $38.75 | $40.09 | $41.47 | +0.02% |
| Aug 3 | $38.21 | $40.09 | $42.07 | +0.03% |
| Aug 4 | $37.81 | $40.10 | $42.53 | +0.05% |
| Aug 5 | $37.47 | $40.11 | $42.92 | +0.07% |
| Aug 6 | $37.18 | $40.11 | $43.28 | +0.08% |
| Aug 7 | $36.92 | $40.12 | $43.60 | +0.10% |
| Aug 8 | $36.68 | $40.13 | $43.90 | +0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $36.68 | $40.13 | $43.90 | +0.12% |
| Week 2 | $35.38 | $40.17 | $45.62 | +0.23% |
| Week 3 | $34.43 | $40.22 | $46.99 | +0.35% |
| Week 4 | $33.65 | $40.27 | $48.19 | +0.47% |
| Week 5 | $32.98 | $40.32 | $49.28 | +0.59% |
| Week 6 | $32.39 | $40.36 | $50.30 | +0.71% |
| Week 7 | $31.86 | $40.41 | $51.25 | +0.82% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation.
The company was incorporated in 2015 and is headquartered in New York, New York.
LB Pharmaceuticals Inc (LBRX) is currently trading with a price of $39.00 and a market cap of $1.12B, ranking 2464 by market capitalization. The current price provides a benchmark for the company’s market position within the healthcare sector.
Forecast data indicate a bullish path beyond 2026, with the 2026 average price listed at $39.00 and a high of $53.79. From 2027 onward, the model projects substantial upside, with 2027 average $48.83 and rising to $64.08 in 2028, then to $88.91 in 2029 and higher in subsequent years. The long-run trajectory points to significant upside through 2050, with the 2050 average priced at $781.75.
A major floor 42.0% below — a decisive break under it would weaken the trend.
The nearest floor, 25.5% below — buyers have tended to step in here.
Price is pressing into resistance (2.0% away) — a breakout level to watch.
A major ceiling 19.7% above — clearing it would confirm fresh momentum.
Key LBRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LBRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $37.94 | Buy | $38.45 | Buy |
| MA 10 | $35.84 | Buy | $36.66 | Buy |
| MA 20 | $34.27 | Buy | $34.84 | Buy |
| MA 50 | $31.32 | Buy | $32.35 | Buy |
| MA 100 | $29.61 | Buy | $29.82 | Buy |
| MA 200 | $24.79 | Buy | $26.37 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 71.95 | Sell |
| Stoch RSI (14) | 86.57 | Sell |
| CCI (20) | 184.11 | Buy |
| Williams %R (14) | -7.95 | Info |
| MACD (12,26,9) | 0.72 | Buy |
| ROC (12) | 24.63 | Buy |
| Bollinger %B (20,2) | 1.02 | Sell |
| Stochastic %K (14) | 92.05 | Sell |
| TRIX (15) | 0.58 | Buy |
| Awesome (5,34) | 5.17 | Buy |
| Ultimate (7,14,28) | 73.27 | Sell |
| Momentum (10) | 8.67 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 40.54 | Sell |
| ADX (14) | 25.29 | Buy |
| ATR (14) | 1.06 | Info |
The 30-day technical picture is bullish. RSI(14) is 70, indicating strong near-term momentum.
Moving averages show the trend with SMA50 at $30.80 and SMA200 at $24.54. Support is at $27.66 and resistance at $39.00, framing the near-term range. The 30-day price range spans from $31.06 to $48.97, highlighting a constructive footing for the stock in the short term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.03 | $40.08 | $55.25 | 0% | Neutral | |
| $37.43 | $50.27 | $72.73 | +25% | Bullish | |
| $46.41 | $65.72 | $100.85 | +64% | Bullish | |
| $61.67 | $91.34 | $146.61 | +128% | Bullish | |
| $70.55 | $108.78 | $181.23 | +171% | Bullish | |
| $73.32 | $117.35 | $201.90 | +193% | Bullish | |
| $83.51 | $138.47 | $245.11 | +245% | Bullish | |
| $85.65 | $146.89 | $266.73 | +266% | Bullish | |
| $87.89 | $155.73 | $289.44 | +289% | Bullish | |
| $107.03 | $195.77 | $371.75 | +388% | Bullish | |
| $156.69 | $333.41 | $691.60 | +732% | Bullish | |
| $359.12 | $798.04 | $1,835.49 | +18.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $19.03 | $40.08 | $51.56 | +0.00% |
| September 2026 | $34.20 | $41.35 | $52.03 | +3.18% |
| October 2026 | $33.26 | $40.70 | $52.12 | -1.59% |
| November 2026 | $33.93 | $41.93 | $54.46 | +3.02% |
| December 2026 | $33.67 | $41.99 | $55.25 | +0.16% |
Click any year to see its month-by-month LBRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, LBRX could reach as high as $55.25, with a base case around $40.08 and support toward $19.03 — roughly 0% from $40.08. A consolidation phase looks the most probable path here.
Expect LBRX to range from $37.43 to $72.73 through 2027. The $50.27 average target implies a +25% move from current prices. That is up +25% on the projected 2026 average. Momentum favours further upside here.
The LBRX price prediction for 2028 points to an average of $65.72 (low $46.41, high $100.85) — a potential gain of +64% on today's $40.08. Buyers look set to stay in control over this stretch.
In 2029, LBRX is projected to trade between $61.67 and $146.61, averaging $91.34 — a potential gain of +128% from today's $40.08. That is up +39% on the projected 2028 average. Momentum favours further upside here.
LB Pharmaceuticals Inc's 2030 outlook centres on $108.78, within a $70.55 to $181.23 range. That is up +19% on the projected 2029 average. That marks a +171% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, LBRX could reach as high as $201.90, with a base case around $117.35 and support toward $73.32 — roughly +193% from $40.08. Momentum favours further upside here.
Expect LBRX to range from $83.51 to $245.11 through 2032. The $138.47 average target implies a +245% move from current prices. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The LBRX price prediction for 2033 points to an average of $146.89 (low $85.65, high $266.73) — a potential gain of +266% on today's $40.08. Momentum favours further upside here.
In 2034, LBRX is projected to trade between $87.89 and $289.44, averaging $155.73 — a potential gain of +289% from today's $40.08. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
LB Pharmaceuticals Inc's 2035 outlook centres on $195.77, within a $107.03 to $371.75 range. That is up +26% on the projected 2034 average. That marks a +388% change versus current levels. Momentum favours further upside here.
By 2040, LBRX could reach as high as $691.60, with a base case around $333.41 and support toward $156.69 — roughly +732% from $40.08. Buyers look set to stay in control over this stretch.
Expect LBRX to range from $359.12 to $1,835.49 through 2050. The $798.04 average target implies a +18.9x move from current prices. That is up +139% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in LBRX today (≈ 24.9501 LBRX) could be worth
$19,911.12
+$18,911.12 (+1891%) by 2050 · US Dollar
Based on the average projected LBRX price of $798.04 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LBRXwould be worth at today's price.
$1,000 invested in LBRX on Sep 11, 2025 (≈ 57.803471 LBRX) would be worth
$2,316.76
+$1,316.76 (+131.7%) today · 2.32× · US Dollar
Based on a LBRX entry price of $17.3 vs. today's $40.08.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $35.01 | $1,144.82 | +14.5% |
| 1 month ago | $31.89 | $1,256.82 | +25.7% |
| 3 months ago | $31.43 | $1,275.21 | +27.5% |
| 6 months ago | $22.91 | $1,749.45 | +74.9% |
| All time ago | $17.3 | $2,316.76 | +131.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LBRX forecast.
Our base-case forecast reaches $80.00 around 2029.
Implied market cap at $80.00: $2.29B
In the multi-year forecast, the asset exhibits a bullish outlook with rising averages and expanding price targets. The 2026 average is $39.00, with a max of $53.79, and an implied neutral sentiment for 2026. Beyond 2026, the forecast shows a pronounced uptrend: 2027 average $48.83 (ROI 25.2%), 2028 average $64.08 (ROI 64.3%), and 2029 average $88.91 (ROI 128%).
By 2030, the average is projected at $106.49 (ROI 173.1%), continuing higher through 2031 at $115.44, 2032 at $135.77, 2033 at $144.13, 2034 at $152.67, and 2035 at $190.95 (all with bullish sentiment). The forecast then accelerates further: 2040 average $329.41 (ROI 744.6%), and 2050 average $781.75 (ROI 1904.5%), both marked bullish.
These figures are estimates and not guarantees. The path assumes the continuation of favorable conditions reflected in the forecast, but actual results may vary due to multiple factors.
Tap a question to reveal the answer.
2030 min $68.54, avg $106.49, max $178.63 with ROI 173.1% and sentiment BULLISH.
Forecasts show a bullish sentiment beyond 2026, with 2027 avg $48.83, 2028 $64.08, 2029 $88.91, and 2030 $106.49 on average. The 2026 result is neutral with an avg of $39.00, suggesting potential upside over time but not a guarantee.
Yes. The forecast indicates a max of $200.05 in 2031, with higher maximums in later years (2032 max $242.16), implying the possibility of exceeding $200 under the projected path.
Current price is $39.00 and market cap is $1.12B.
2050 min $351.79, avg $781.75, max $1,798.02 with ROI 1904.5% and sentiment BULLISH.
LB Pharmaceuticals Inc Community Discussion
0Share your LB Pharmaceuticals Inc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.